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We have suggested before that thymus-independent immune responses to certain 
antigens are caused by special properties of the antigens concerned, namely that they 
are  B-cell  mitogens  (1).  Actually  all  thymus-independent  antigens  (TI) 1 we  have 
tested so far were found to be competent to activate DNA and polyclonal antibody 
synthesis in nonprimed B cells cultured in vitro (2). Since the TI antigens can directly 
induce division and differentiation  in B cells, it is evident that T-B cells cooperation 
would not be required for the induction of specific immune responses. However, there 
is an apparent paradox between the ability of a mitogen to induce an antigen-specific 
immune response to its own antigenic determinants,  and its ability to activate poly- 
clonal antibody synthesis in all B cells, irrespective of their specificities.  The paradox 
can be  easily  explained  by assuming  two fundamentally different  types  of antigen 
binding to the cell surfaces. At low (immunogenic) concentrations, TI antigens would 
be preferentially bound by lg receptors on specific antigen-binding B cells, whereas at 
high (mitogenic) concentrations also,  other B  cells  (lacking specific receptors for the 
antigenic determinants  of these molecules)  would bind a  sufficient number of mole- 
cules to become activated.  Once triggering concentrations were reached on the cell 
surface,  the cell  would be activated and secrete the immunoglobulin for which it is 
genetically programmed.  In  terms  of this  argument,  T-cell independence  could  be 
considered the most sensitive test for B-cell mitogenicity, since it is the "physiological" 
expression of direct B-cell activation. 
The present experiments  were designed to test  this hypothesis critically,  by 
use  of the  hapten  4-hydroxy-3,5-dinitrophenyl  (NNP)  coupled  to  the B-cell 
mitogen lipopolysaccharide (LPS) (3). The purpose of this work was to invesfi- 
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gate whether  NNP-LPS  molecules  would preferentially  bind  to  NNP-specific 
cells and  activate  them  to  specific anti-NNP  antibody  synthesis  at  such  low 
mitogen  concentrations  that  fail to  activate polyclonal antibody  synthesis.  It 
will be shown that optimal doses of NNP-LPS  for mitogenic activation of high- 
affinity NNP-specific B  cells are several orders of magnitude lower than optimal 
doses required for polyclonal activation. At the latter low concentrations of the 
hapten-mitogen  conjugate,  only hapten-specific  cells are activated.  Thus,  this 
activation gives rise to a  specific, thymus-independent  immune response,  with 
the typical kinetics of an antigen response. 
Materials and Methods 
Mice.--Mice of the inbred strains A, B10.5M, and F1 hybrids between these strains were 
used in different experiments. The mice were used at 4-12 wk of age. Congenitally athymic 
(nude)  mice on BALB/c background were obtained from Bomholtgaard, Ry, Denmark. 
Mitogens.--Lipopolysaccharide (LPS) from Escherichia coli 055: B5 was obtained by phenol 
water extraction according to the method of Westphal et al. (4). For the coupling of NNP to 
LPS, 40 mg of NNP-azide was added  to  100 mg of LPS in 6 ml of carbonate-bicarbonate 
buffer (pH 9.2) and mixed at room temperature for 1 h. The reaction was halted by adding 50 
mg of glycyl-glycine, and the mixture was separated on  a Sephadex G-50 column using 1 M 
potassium buffer for eluation. The first peak collected was passed again in the same column 
after adjusting the pH to 7. The collected material was then dialyzed against distilled water. 
The content of LPS was estimated from the dry weight of the sample, and the NNP content 
was  determined  by  spectrophotometry.  The  final conjugation ratio was  10  --5 M  1WNP/mg 
LPS. LPS or NNP-LPS were dissolved in balanced salt solution  (BSS)  to the desired con- 
centration. 
Antigens  and Immunization.--Sheep  red  blood  cells  (SRBC),  always  obtained  from the 
same sheep donor, were stored in sterile Alsever's solution. The SRBC were washed twice in 
BSS before use.  An analogous procedure was  followed when horse red  cells  (HRBC)  were 
used. 
Haptenated  sheep or horse red cells were prepared as described by Pasanen and Mi~kel/~ 
(5).  NNP-azide  1.0 or 0.01  mg/ml final concentration, respectively, or 4-hydroxy-3-iodo-5- 
nitrophenyl (NIP)-azide (1 mg/ml final concentration) was mixed with washed sheep red cells 
in a carbonate-bicarbonate buffer (pH 9.2)  at room temperature for 45 rain. Haptenated red 
cells were  then  extensively washed  in  BSS.  The NNP  haptenation  procedure  yielded red 
cells with different epitope density referred  to as NNP  nos.  1,  2,  and 3,  respectively. For 
immunization in vitro, approximately 107 red cells were added to each culture dish. 
Preparation of Lymphocytes.--For  studies  on  antibody  synthesis,  spleens were removed 
and teased in ice-cold BSS. The cells were washed three times in 50 ml of cold BSS and sub- 
sequently resuspended in tissue culture medium. For induction of DNA synthesis, spleen and 
lymph nodes were cut in pieces and pressed through a 60 mesh stainless steel screen into BSS. 
The cells were washed three times in 50 ml of BSS (400 g for 10 min) and thereafter resus- 
pended in culture medium to the desired cell concentration. Cellular and viability counts were 
performed in a Burker hemacytometer after staining the damaged  cells  with  0.02~o  trypan 
blue. 
Medium.--For induction of DNA synthesis the medium used was Eagle's minimal essential 
medium  in  Earle's solution  obtained  from  Flow Laboratories,  Irvine,  Scotland,  containing 
gintamine (2 raM),  100 IU of penicillin, and  100 #g streptomycin/ml. In all experiments, 10 
mM of N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (HEPES) buffer (Flow Labora- 
tories) was present in the medium and the pH adjusted to 7.0-7.2.  For induction of immuno- 76  MITOGENIC  TRIGGERING  OF- SPECIFIC  IMMUNE  RESPONSES 
globulin synthesis the same medium supplemented with nonessential amino acids and pyruvate 
was used as described by Mishell and Dutton  (6). 
Sera.--Most experiments were carried  out in serum-free medium,  but in certain experi- 
ments 10% fetal calf serum  (Rehatuin batch no. 268; Armour Pharmaceutical Co., Chicago, 
Ill.) was used to the medium. 
Experimcatal  Procedure.--Activation  of DNA synthesis was  performed  in plastic  tissue 
culture tubes (no. 2054; Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) and I ml of lympho- 
cyte suspension  containing 2  X  10 ~ cells/ml was added to each tube. Thereafter 0.1 ml of the 
mitogens used were admixed. Triplicate cultures were incubated in plastic boxes filled with a 
mixture of 10% CO2, 83% N2, and 7% 02. At various time intervals 2/zCi/ml in a volume of 
0.1 ml of [3H]thymidine (The Radiochemical Centre, Amersham, England; sp act of 5 Ci/mM) 
was added  to each tube.  24 h  later the cultures were harvested by pouring them onto Sar- 
torious membranes (0.8/~m  pore size)  (Membrane Filter GMBH, G6ttingen, West Germany) 
in a  Millipore multimanlfold sample collector (Millipore  Corp.,  Bedford,  Mass.).  The cells 
were successively washed in  15  ml of 0.9%  saline and  4  ml of ice-cold 5%  trichloroacetic 
acid.  The filters were placed in scintillation vials and left to dry overnight. 5 ml of scintilla- 
tion fluid was added to each vial and the samples were counted in a scintillation spectrometer 
(Tri-Carb; Packard  Instrument  Co., Inc., Downers Grove, Ill.). The  data  are presented  as 
counts per minute per culture. 
Induction of antibody synthesis was performed in  plastic Petri dishes  (no.  3001;  Falcon 
Plastics)  1-ml cultures containing 107 ceils were set up in triplicate and incubated at 37°C as 
described above, rocking on a platform at 8 oscillations per min. The cultures were fed daily 
with a nutritional cocktail, as described earlier (7). At various times after onset, the cells were 
harvested and washed three times in BSS before the plaque assay. The cultures were assayed 
individually (indicated by standard errors in tables and figures). 
The hemolytic plaque assay used was modified according to Bullock and Mt~ller (8). In short 
the following procedure was followed: 0.6 ml of 0.5% agar (Bacto Agar; Difco Laboratories, 
Inc., Detroit, Mich.) in BSS with 0.05% DEAE-dextran (Pharmacia Fine Chemicals, Uppsaia, 
Sweden)  was kept at 46°C. 0.05 ml of red cells or haptenated red cells diluted 1:8 in BSS was 
added to the agar together with 0.2 ml of washed lymphocytes and 0.05 ml of guinea pig serum 
(diluted 1:4 in BSS). The mixture was plated in 0.2-ml spread spots on plastic Petri plates and 
incubated for 3 h at 37°C. Plaque-forming cells (PFC) were counted using indirect light. Total 
number of cells were counted in a Coulter counter (Coulter Electronics, Inc., Hialeah, Fla.) 
and the viability was assayed by the trypan blue exclusion test. 
The rosette inhibition assay was performed as described by M611er et al.  (9). Briefly, washed 
spleen cells were mixed in vitro with various concentrations of either LPS or NNP-LPS and 
incubated at room temperature for 30 min. Thereafter, NNP-SRBC target cells were added 
and the cell suspension was immediately centrifuged for rosette-forming cells (RFC) forma- 
tion. The cell suspensions  were kept at 4°C until the enumeration of RFC had been completed. 
RESULTS 
ttaptenation  Does  Not  Interfere  with  the Mitogenic  Properties  of LPS.--The 
purpose of this work was to investigate the activation induced by a strong B-cell 
mitogen  on  cells that  can  specifically bind  the antigenic  determinants  present 
on the mitogen molecules. We selected the determinant  NNP  because  the de- 
tection method (hemolytic plaque assay) is convenient, relatively high numbers 
of PFC can be detected in nonprimed animals against this determinant  (8), and 
the affinity distributions among the specific cells can be easiy determined (5, 10). 
However, the NNP-LPS  preparation would be suitable for this  purpose  only  if 
LPS  retained  full mitogenic activity even after haptenation.  In order to study A.  COUTINHO,  E.  GRONOWICZ, W.  W.  BULLOCK, G.  MOLLER  77 
this, a wide range of concentrations of NNP-LPS was tested in parallel with a 
nonhaptenated preparation of LPS, for the ability to activate DNA synthesis in 
normal  spleen  cells.  Results  of one  experiment are  shown in  Fig.  1.  Normal 
spleen cells were cultured together with either preparation of the mitogen, and 
activation of DNA synthesis was measured after 2 days in culture, when peak 
activity occurs (7). The dose-response curves were similar for both forms of the 
mitogen, indicating  that  they did not  differ with  regard  to nonspecific mito- 
genic activation of B  cells. 
7 
0~05  °;2  2°; 
MITOGEN  CONC[NTRAIIONS  (pg/  ml) 
FIo. 1.  Incorporation of [3H]thymidine (means of triplicate cultures, the SE being smaller 
than the symbols) into normal B10.5M spleen cells cultured for 2 days in serum-free medium 
(2  X  106 cells/ml per culture) with various concentrations of LPS  (A---A) or NNP-LPS 
(•--•  ). Background incorporation in nonstimulated cultures is also indicated (O). 
NNP-LPS Is Preferentially Bound by NNP-Specific Cells.--The experimental 
design requires that the NNP determinants on the LPS molecule can be spe- 
cifically bound by anti-NNP receptors on lymphocytes. To study whether this 
was the case with the preparation of NNP-LPS used,  we employed the tech- 
nique of inhibition of hapten-specific rosette-forming cells by soluble hapten, as 
described by MSller and Miikel~  (11).  In this technique,  lymphocytes are al- 
lowed to react with soluble hapten for 30 rain at room temperature, after which 
indicator erythrocytes (NNP-coated SRBC) are added and the rosettes formed 
at 4°C. If soluble hapten is present during the incubation period it will combine 
with specific cell receptors and will prevent further antigen binding when given 
on the erythrocytes. Therefore, rosette formation is inhibited and the phenome- 78  MITOGENIC  TRIGGERING  OF  SPECIFIC  IMMUNE  RESPONSES 
non has been shown to depend on the concentration of the hapten and on the 
affinity of the receptors on the specific cell population (8). If NNP determinants 
on the LPS molecule were available for the binding by NNP-specific cells,  the 
NNP-LPS preparation would also efficiently inhibit NNP-specific rosette-form- 
ing cells. And as can be seen in Fig. 2, a typical inhibition curve for hapten con- 
jugates was found with NNP-LPS, whereas LPS did not inhibit rosette forma- 
tion. 
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FIG. 2.  Inhibition  of NNP-RFC by NNP-LPS and LPS. Spleen cells from AxSM mice 
primed 6 days before with NNP-HRBC were incubated with various concentrations of NNP- 
LPS  (O--Q),  LPS  (A---A), or with  BSS  (control), and  the rosettes  formed with  NNP- 
SRBC no. 3. The percent suppression of control was calculated by the formula: 
i00 X  no. of RFC in control  -- no. of RFC in experimental group/no, of RFC in control. 
Differential Dose Requirements for Activation of NNP-Specific  Cells and for 
Polydonal Activation.--Once  it had been established  that  a  mitogen molecule 
containing NNP determinants  was preferentially bound to NNP-specific cells, 
the hypothesis outlined in the introduction was tested. It is well known that B- 
cell  mitogens  activate  immunoglobulin  synthesis  and  secretion  in  nonprimed 
B-cell populations, irrespective of their specificities (3). Therefore, this prepara- 
tion of hapten-mitogen should also be able to activate polyclonal antibody syn- 
thesis. However, if our hypothesis is correct, activation of antibody synthesis in 
NNP-specific B  cells would occur at  lower concentrations  of NNP-LPS  than 
activation of non-antigen-specific cells, since the mitogen would be preferentially 
bound to NNP-specific cells and triggering concentrations would be reached on 
the surface of these cells at lower concentrations of the mitogen in the medium. A.  COUTINHO, E.  GRONOWICZ, W.  W.  BULLOCK, O.  MOLLER  79 
Therefore,  a  wide  range  of  NNP-LPS  concentrations  was  added  to  normal 
spleen  cells in culture,  and  the mitogen-induced  PFC response was measured 
after 2  days in culture  (7).  The activation  of antibody production against an 
unrelated antigen  (SRBC)  was determined as a  measure  of polyclonal activa- 
tion,  whereas the stimulation of specific cells was tested by enumerating anti- 
NNP PFC. Moreover, it is known that the avidity of the anti-NNP PFC can be 
studied by using target red cells coated with different epitope  densities  in the 
hemolytic plaque assay (5,  10). Therefore, we could study the avidity distribu- 
tions of the anfi-NNP PFC activated by different concentrations of NNP-LPS. 
Fig.  3  shows the results  of such  an  experiment.  The dose-response profile for 
polyclonal  activation,  as measured  by anti-SRBC  PFC,  was  the  same as  re- 
ported elsewhere for LPS preparations  (3): increased numbers of PFC starting 
to appear at  LPS concentrations about 0.1/zg/ml,  the response gradually in- 
creasing with higher concentrations, until a plateau was reached with concentra- 
tions of the mitogen of about  10/zg/ml. This  shows that  the hapten-mitogen 
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FIO. 3.  Normal  B10.5M spleen cells were incubated  in triplicate  cultures  with  different 
concentrations  of NNP-LPS in serum-free medium  (t0  X  10  6 cells/ml per culture)  and the 
number of PFC was determined after 2 days against: NNP-SRBC no. 3, no. 2, and no. 1, and 
SRBC. Numbers of anti-SRBC  PFC were subtracted  from the numbers of anti.NNP SRBC 
of different epitope densities, for each culture, to obtain absolute numbers of anti-NNP PFC 
of each avidity group. Background numbers of PFC in nonstimulated cultures were subtracted 
and the percent  of optimal response of each avidity distribution  was calculated. Anti-SRBC 
PFC  "k--'k;  high-avidity  anti-NNP  PFC  e--O;  low-avidity  anti-NNP  PFC 1~---O; 
intermediate-avidity  anti-NNP PFC  •  ...... A. 80  MITOGENIC  TRIGGERING OF  SPECIFIC  IMMUNE  RESPONSES 
conjugate has an unimpaired ability to activate polyclonal antibody synthesis. 
However, the anti-NNP response induced by the haptenated mitogen showed a 
completely different dose-response curve. Optimal concentrations for the acti- 
vation of high-affinity NNP-specific B  cells  (0.00256-0.0128/zg/ml)  failed to 
activate polyclonal antibody (Fig. 3) and DNA (Fig. 1) synthesis. Furthermore, 
the anti-NNP-specific cells  were inactivated by concentrations of NNP-LPS 
that were optimal for polyclonal activation, presumably by the same type of 
mechanism that accounts for the inactivation of all B cells by supraoptimal con- 
centrations of any B-cell  mitogen. However, this high dose inactivation pro- 
ceeded faster (as a function of NNP-LPS concentration) for specific cells, and it 
follows that the dose-response profile is not only shifted to the left for specific 
cells, but also was more narrow than for polyclonal activation. In Fig. 3 is also 
shown the response induced by NNP-LPS in NNP-specific B cells of lower aver- 
age affinity for the hapten, detected as PFC using a higher epitope density on 
the target red cells. Cells of very low affinity showed a dose-response curve more 
similar to the polyclonal curve, and cells of median affinity had dose require- 
ments in between the high- and low-affinity cells. With the highest epitope coat 
it was indeed possible to detect very high numbers of PFC (12) that could be 
shown to be of very low affinity for the hapten, most likely representing many 
different specificifies.  When responses to a  cross-reacting antigen (NIP)  were 
measured  (results not shown),  optimal activating concentrations were higher 
than for low-affinity NNP-specific cells, but lower than for polyclonal activa- 
tion. However, a significant response was still obtained with very low concentra- 
tions that failed to activate polyclonal antibody synthesis. This later finding can 
be explained in terms of higher cross-reactivity displayed by high-affinity anti- 
bodies (13). The same type of findings were obtained by using a different prepa- 
ration of LPS that had been coupled to fluorescein isothiocyanate (G. M611er 
and A. Coutinho, unpublished observations). 
Inhibition of Specific Binding Prevents Preferential A chvation of Specific Cells. 
--If the results described above were due to preferential binding of the hapten- 
mitogen conjugate to specific  hapten-binding B  cells,  it would be possible  to 
prevent  the preferential  ("specific") activation of NNP-binding cells,  by  in- 
hibiting the specific  binding of the  mitogen to these cells.  It has been shown be- 
fore (14)  that the immune response of mouse spleen cells in vitro to  NNP-red 
cell conjugates could be inhibited by adding free hapten  (NNP-e-aminocaproic 
acid [cap]) to the cultures, presumably by inhibiting binding of the  immuno- 
genic material. We have used the same molar concentrations of NNP-cap  that 
had been used for the inhibition of primary immune responses in the Mishell- 
Dutton system, for studying the inhibition of mitogenic stimulation induced 
by NNP-LPS. Normal spleen cells were cultured with doses of NNP-LPS opti- 
mal for activation of high-affinity NNP-specific cells, or alternatively, with op- 
timal concentrations for polyclonal activation that completely suppressed the 
specific anti-NNP response. In the same experiments, equal concentrations of A.  COUTINHO, E.  GRONOWICZ, W.  W.  BULLOCK, G.  MOLLER  81 
nonhaptenated LPS were tested in parallel. As shown in Fig. 4, optimal concen- 
trations of NNP-LPS were completely nonactivating when NNP-cap was pres- 
ent in the cultures,  the numbers of PFC being the same as the background in 
nonstimulated  cultures  and  in  cultures  treated  with  the  same  submitogenic 
dose of nonhaptenated LPS. On the other hand, the inactivation induced by high 
doses of NNP-LPS was prevented by free hapten,  and the anti-NNP response 
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FIG. 4.  Normal B10.5M spleen cells were incubated  in triplicate  cultures  in serum-free 
medium with the indicated  concentrations of NNP-LPS (filled bars), NNP-LPS in presence 
of 2  X  10  --4 M NNP-cap (hatched bars),  or LPS (open bars),  and the PFC response was 
measured after 2 days against NNP-SRBC no. 3, and SRBC. Values are given as means and 
SE of anti-NN'P PFC (SRBC PFC subtracted  for each culture) in triplicate cultures. Back- 
ground numbers of PFC in nonstimulated cultures are also indicated. 
in this case was comparable to that induced by the same concentration of non- 
haptenated LPS. It seems likely, therefore, that the preferential mitogenic ac- 
tivation  induced  in  hapten-specific  cells  by  submitogenic  concentrations  of 
NNP-LPS was due to the fact that only specific cells bound a sufficient number 
of mitogen molecules to become activated. Free hapten did not prevent activa- 
tion of specific cells when high NNP-LPS concentrations were used, although the 
hapten prevents  specific binding  of NNP-LPS  to NNP-reactive cells.  In the 
presence of free hapten specific cells can only bind the conjugate nonspecifically 
as any other B  cell. The fact that  these specific cells  could still be activated, 82  MITOGENIC  TRIGGERING  OF  SPECIFIC  IMMUNE  RESPONSES 
even  when  the  Ig  receptors  were  presumably  occupied  by  the  free  hapten, 
strongly indicates that B-cell activation does not take place via these surface 
receptors. 
NNP-LPS  as an Antigen.- 
Specificity:  In  the  preceding  experiments,  the  activation  of  NNP-specific 
cells was measured by PFC formation after 2  days of in vitro incubation with 
the mitogen conjugate. Though the responses were mitogen induced, they were 
strictly specific for the hapten at certain concentrations of the hapten-mitogen 
conjugate. As shown above, optimal concentrations of NNP-LPS for induction 
of high-affinity NNP-specific cells did not induce increased DNA or polyclonal 
antibody synthesis, nor could the same concentrations of nonhaptenated  LPS 
activate polyclonal or NNP-specific responses. Moreover, it could be shown that 
these  low  concentrations  of  NNP-LPS  activate  exclusively, or mostly,  high- 
affinity anti-NNP  cells, since small or no  increases in  PFC  over background 
were found in the same cultures, when tested against target cells coated with a 
higher epitope density (Table I). On  the other hand,  the absolute numbers of 
high-affinity anti-NNP PFC induced by these concentrations of NNP-LPS were 
always as high  as, and usually higher  than, the numbers of anti-NNP PFC of 
the  .same affinity distribution induced  by optimal  concentrations  of  nonhap- 
tenated LPS, when measured after 2 days of culture, at the peak of polyclonal 
TABLE I 
Avidity Distribution  of the Cells Responding  to NNP-LPS or LPS 
Anti-NNP PFC/culture detected with 
High epitope density  Ratio low: high  Mitogen in culture  Low epitope density  avidity PFC 
(high-avldity cells)  (high-and low-  (low-avidity 
avidity cells)  cells) 
NNP-LPS 0.0025 #g/ml 
Exp. 1"  978  4-  71  1,057  4- 38  79  0.08 
2~  1,087  4-  158  1,410  4-  111  323  0.29 
3~  1,643  -4- 78  2,085  ±  92  442  0.27 
LPS 100#g/ml 
Exp. 4*  318  -4-  70  3,702  -4- 31  3,383  10.61 
5*  577  -4- 27  4,700  -4-  104  4,123  7.15 
6*  568  -4- 28  5,172  -4- 321  4,604  8.11 
Normal B10.5M  spleen cells were stimulated in triplicate cultures in serum-free  medium 
by NNP-LPS or LPS at the indicated concentrations. The PFC  response  was  determined 
against NNP-coated SRBC with a low (for high-affinity cells) or with a high (for low-affinity 
ceils) epitope density. Numbers of anti-SRBC PFC were subtracted for each culture, as well 
as the anti-NN'P PFC  of  the corresponding  avidity group  detected in  background non- 
stimulated cultures.  Since all PFC of high avidity are also visualized with a higher epitope 
density, whereas the reverse does  not occur,  absolute numbers  of low-avidity PFC  were 
obtained by subtracting numbers of high-avidity PFC from detected numbers of low-avidity 
PFC for each culture. 
* Harvested after 2 days in culture. 
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activation These findings indicate that all the high-affinity anti-NNP-specific 
cells, and only those, are activated by these submitogenic concentrations of the 
hapten-mitogen conjugate. 
Kinetics:  The present results suggest  that mitogenic  activation of normal 
spleen cells in vitro can give rise to specific immune responses. However, it has 
been previously reported that the kinetics of the in vitro antibody responses is 
markedly different between mitogenic and antigenic responses. Thus, the mito- 
gen-induced responses are characterized by a sharp peak on day 2 of culture, and 
background levels are reached after 4 or 5 days (7). Contrariwise,  antigenic re- 
sponses appear after the 1st days of culture and reach a maximum on day 4 or 5 
(6). We followed cultures stimulated with various concentrations of NNP-LPS 
or LPS for up to 5 days and measured the PFC responses against NNP and 
SRBC. Some of the results are summarized in Fig. 5 and Table II. Mitogenic 
activation by optimal doses of LPS followed the expected kinetics,  for both 
SRBC and NNP PFC, with a sharp peak on day 2 of culture.  However, the re- 
sponse to optimally stimulating doses of NNP-LPS for high-affinity  NNP-spe- 
cific cells increased throughout the whole culture period. 
It could be argued that low concentrations of nonhaptenated LPS would have 
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DAYS  IN  CULTURE 
FIG. 5.  Normal B10.5M spleen cells were cultured in serum-free medium (10  X  106 cells/ 
ml per culture) in the presence of 100/zg of LPS or 0.0025/zg of NNP-LPS in triplicate cul- 
tures. At different days the PFC response was detected against NNP or SRBC. Background 
numbers of  PFC  in  nonstimulated cultures were subtracted and  the percent of maximal 
response per culture was calculated each day.  •  ...... •  anti-NNP  PFC with 100 #g LPS; 
O----Oanti-SRBC PFC with 100/zg LPS;  •--O  aflti-NNP PFC with 0.0025/zg NNP-LPS 
(no anti-SRBC PFC above background were detected with 0.0025 #g NNP-LPS). The mean 
of absolute numbers of PFC above backgrounds are indicated in parentheses. 84  I~ITOGENIC  TRIGGERING  OF  SPECIFIC  IMMUNE  RESPONSES 
TABLE  II 
Kinetics and Specificity of the "Late" PFC Response of Normal Spleen Cells 
to NNP-LPS or LPS 
PFC/culture against 
Mitogen in culture  Day 3  Day 4 
SRBC  NNP  SRBC  NNP 
--  15  -4-  8  27  -4-  12  15  -4-  7  18  -4-  11 
LPS 0.0025/zg/ml  15  .4- 0  35  -4-  15  13  :h  2  15  -4-  7 
NNP-LPS 0.0025 #g/ml  15  -4-  7  1,670  ±  78  10  -4- 2  1,876  -4-  83 
For culture and plaque assay conditions, see footnote of Table I. Anti-NNP PFC detected 
with a low epitope density on the target red cells. 
the same effect and cause some PFC response to appear later in the culture. But, 
as shown in Table II, this is not the case. When the same low concentration of 
LPS and NNP-LPS was tested in parallel, LPS did not induce any stimulation 
of PFC  against  NNP  or  SRBC,  whereas  NNP-LPS  induced  a  specific anti- 
NNP response, which peaked on day 4 of culture. 
Several reasons may be responsible for the deterioration of the polyclonal re- 
sponse after the 1st 2 days, such as direct cell damage by high doses of mitogen, 
deterioration of the culture conditions as a  result of the intense metabolic ac- 
tivity in  these cultures,  because a  large proportion of the cells are activated, 
shortage of nutrients  and/or mitogen molecules, and  the release of toxic ma- 
terials by activated and  damaged cells.  Whatever the  reason,  it is clear that 
when only a  small number of lymphocytes are activated, as in the case of the 
specific responses induced  by NNP-LPS,  the  response follows the  kinetics of 
antigen responses, even though the stimulus was mitogenic. 
The responses to NNP-LPS are thymus independent:  The response to the NNP 
determinant on the hapten-mitogen conjugate appears to fit the generally ac- 
cepted  definition  for antigenic  responses,  since it  is  specific and  exhibits  the 
kinetics  of  this  type of responses.  However,  these  experiments also  strongly 
suggest that this response is the result of the mitogenic stimulation of specific 
NNP-binding cells confronted with the mitogenic properties of the LPS mole- 
cule. If this were the case, the anti-NNP response should be expected to be in- 
dependent of helper cells,  such as T  cells.  The fact that the response can be in- 
duced in serum-free media (all the experiments above) by itself suggests thymus 
independence, since it was shown before that thymus-dependent (TD) antigens 
do not induce primary in vitro responses in this type of system, unless further 
nonspecific B-cell stimuli are provided (15). 
We tested the anti-NNP responses in spleen cells from congenitally athymic 
mice, and compared them with the responses induced in normal mouse spleen 
cells, after stimulation with both NNP-LPS and NNP-HRBC. The later anti- 
gen was choosen because it lacks mitogenic activity and is, therefore, highly TD 
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on a nonmitogenic carrier, the hapten density presumably being much higher on 
the non mitogenic carrier. According to our hypothesis, different requirements 
for helper cell activity should be expected for each of the carriers. 
As shown in Table III, NNP-LPS induced comparable anti-NNP responses in 
normal or T-deficient (nude) spleen cells,  whereas NNP-HRBC, which was a 
good immunogen when normal spleen cells were used, did not induce any re- 
sponse above background values in nude spleen cells. It can also be seen that the 
numbers of PFC induced by NNP-HRBC in normal spleen cells were consider- 
ably higher than the numbers induced by NNP-LPS. This could be explained 
by amplification mechanisms involved in T-cell helper activity, which do not 
participate in the response to NNP-LPS, or by the presence of fetal calf serum 
(FCS) in NNP-HRBC cultures, since FCS is required to support that type of 
responses (15). 
TABLE  III 
Thymus Independence of the In Vitro Antibody Response to NNP when Coupled to LPS 
Antigen in culture  Spleen cells 
Anti-NNP PFC/106 recovered viable cells 
Day 3  Day 4 
NNP-HRBC*  Normal  713  -4-  126  3,304  4-431 
"Nude"  n.t.~  15  +  2 
NNP-LPS§  Normal  750  -4-  13  960  ±  128 
"Nude"  844  4-  40  1,012  4-  50 
Since induction of in vitro responses by NNP-HRBC  requires the presence of FCS  (15), 
these cultures received  serum supplementation as described under Materials  and  Methods. 
The PFC  numbers shown are the differences in numbers of PFC  in antigen-stimulated cul- 
tures above the numbers of PFC detected in background, nonstimulated cultures. For other 
culture and plaque assay conditions see footnote of Table I. Anti-NNP PFC detected with a 
low epitope density on the target red ceils. 
* Approximately 10 7 NNP-coated HRBC no. 2 were added to each culture dish. 
:~ Not tested. 
§ 0.0025 #g/ml. 
DISCUSSION 
Since TI antigens can activate B  cells  directly (in the absence of T-helper 
cells)  during the induction of a primary specific immune response, it has been 
suggested before that they should also be able to activate all B cells nonspecifi- 
cally, provided a sufficient number of molecules could interact with the B-cell 
membranes (1). This was found to be the case. Thus, all TI antigens tested were 
shown to be nonspecific B-cell mitogens, capable of activating DNA and poly- 
clonal antibody synthesis in nonprimed populations of spleen cells deprived of T 
cells (2). It should be pointed out that this was found to occur in vitro, as well 
as in vivo. The ability of TI molecules to trigger B cells directly (B-cell mito- 
genicity) could explain their thymus independence. 
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the specificity of the immune responses induced by TI antigens. In view of the 
characteristic dose-response  curves for polyclonal immunocyte activation ex- 
hibited by TI antigens, it seemed likely that immunogenic concentrations of 
these antigens would be too low to activate nonspecific lymphocytes. However, 
lymphocytes having  specific  immunoglobulin  receptors  for  the  TI  antigen 
would bind these molecules both "nonspecifically" (as any other B cell) and, in 
addition, specifically by binding their antigenic determinants. This additional 
specific  binding would result in a  larger number of mitogenic molecules being 
bound to the specific cells, as compared to other B cells. It follows that triggering 
concentrations of the activating molecules would only be reached selectively on 
the surface of specific cells. Since B cells can be activated directly by the mito- 
genic properties of the TI antigen, the response at these concentrations will be 
detected as a  specific  and thymus-independent immunocyte activation,  even 
though the basic mechanism of triggering is the same as that activating poly- 
clonal antibody synthesis in other B  cells,  when higher concentrations of the 
antigen are used, which allow sufficient nonspecific binding to all B  cells  for 
triggering. 
This specific preferential binding of the antigenic determinants on TI (mito- 
gen) molecules to specific Ig receptors makes the dose-response profiles markedly 
different between specific and mitogenic responses. Mitogenic (polyclonal) acti- 
vation  should  occur  at  higher  concentrations, whereas  induction  of  specific 
antigen-binding cells would occur at lower concentrations. However, high con- 
centrations should turn  off the specific  cells  at  the same time as  nonspecific 
cells  are  activated,  because  these concentrations would be  supraoptimal  for 
specific binding lymphocytes resulting in paralysis. This is the case for LPS (3) 
and all the other TI antigens previously shown tO be B-cell mitogens. They all 
exhibit mitogenicity at concentrations several orders of magnitude higher than 
the doses reported to be immunogenic in vitro or in vivo (2, 16-20).  TI antigens 
are also known to be efficient in inducing specific  high-zone paralysis and we 
have shown before that paralytic doses of SIII are mitogenic for other (non- 
specific) B cells in the same animals (1). 
All these considerations are clearly supported by the experiments described 
above, using the hapten NNP coupled to the B-cell mitogen LPS. Moreover, it 
was demonstrated that the differential dose requirements for specific and poly- 
clonal activation, respectively, were dependent upon binding of the NNP de- 
terminants (coupled to the LPS molecules) to the NNP-specific cells because: 
(a)  Preferential activation or inactivation of NNP-binding cells by NNP-LPS 
could be prevented when specific  binding was  inhibited by  free NNP  in the 
cultures;  (b)  NNP-reactive  cells  having a  lower avidity for the haptenic de- 
terminants showed a dose-response profile, which was more similar to nonspe- 
cific B cells,  than that of high-avidity NNP-reactive cells. The latter result is 
also predictable from the hypothesis presented above, because low-avidity NNP 
cells would not bind NNP-LPS as efficiently as high-avidity NNP cells. A.  COUTINHO~  E.  GRONOWICZ~ W.  W.  BULLOCK,  G.  MOLLER  87 
These experiments demonstrate that activation of normal spleen cells by a 
nonspecific B-cell mitogen can result in an exclusively specific immune response 
to the antigenic determinants present on the mitogen molecule, if suitable con- 
centrations of the mitogen are used. This response is thymus independent, and 
its specificity is indistinguishable from a  thymus-dependent immune response 
to the same hapten. Even so, it seems highly unlikely that the basic mechanism 
for triggering induced by NNP-LPS in NNP-specific cells at low concentrations 
is different from that exerted by the same molecule in nonspecific cells at higher 
concentrations. The activating (mitogenic) properties of the NNP-LPS mole- 
cules are most likely provided by its structure and/or by its mitogenic determi- 
nants, but not by the NNP determinants, since NNP determinants on TD car- 
riers do not activate B cells directly. Therefore, the haptenic determinants ap- 
pear  to be  exclusively responsible for the specific  binding of the nonspecific 
mitogen. Our experiments clearly suggest that the only specific  step in B-cell 
activation is the binding to the cell membrane, whereas the actual triggering is 
completely nonspecific. 
However, if it is assumed that extensive cross-linking of surface Ig receptors 
is the fundamental triggering signal (21, 22), it could be argued that such cross- 
linking would take place in NNP-specific cells, because the NNP  determinants 
were repeated on the LPS molecules. We have pointed out before that  cross- 
linking--if at all necessary for B-cell activation--is not sufficient, because highly 
hapten-substituted TD proteins do not induce thymus-independent antihapten 
immune responses  (21, 23,  24),  whereas low levels of hapten substitution can 
lead to thymus-independent responses, if the carrier is a TI antigen (B-cell mito- 
gen) (16, 25). Moreover, extensive cross-linking of Ig receptors by bivalent anti- 
mouse Ig antibodies does not lead to B-cell activation (26).  It seems  likely, 
therefore, that presentation of antigen under conditions leading to extensive 
cross-linking of the antigen-binding receptors cannot be the mechanism of B-cell 
activation. Rather, triggering by TI antigens appears to be the consequence of 
the totally nonspecific mitogenic properties of these antigens. Another set of 
findings is also most likely explained by this hypothesis, namely that TD anti- 
gens (SRBC or fowl gamma globulin) can, directly immunize B cells in the pres- 
ence of TI antigens (B-cell mitogens) like LPS or polymerized flagellin (27-29). 
These experiments force us to question a  generally accepted dogma in im- 
munology, namely that the Ig receptors on the B-cell  surface are directly re- 
sponsible for triggering the cell subsequently to their specific combination with 
the antigen. Critical evidence to support this dogma does not exist at present. 
On the other hand, several lines of experimentally supported evidence are ac- 
cumulating to directly suggest that the actual triggering event of B cells is al- 
ways basically nonspecific (1, 2, 15, 27, 30-32). In terms of this concept the Ig 
receptors are only passive focusing devices for mitogens  or for T  cells--the 
latter also providing a mitogenic stimulus. The specificity of the responses is de- 
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ceptors are not involved in the delivery of the activation signal. The actual 
triggering of the cell is nonspecific and probably carried out via other compon- 
ents of the cell membrane. 
Theories  maintaining  that  B-cell  activation  is  caused  by  specific  signals 
usually explain activation in terms of two signals, one being the specific recog- 
nition of the antigen by the Ig receptor, involving an allosteric modification of 
the receptor, and the other being basically nonspecific such as cross-linking (22, 
33)  or "pulling" (34) of Ig receptors, binding of associative antibody (35),  or 
nonspecific activating factors  generated  by  helper  cells  (T  cells  [36, 37]  or 
macrophages [Schrader, J. W., personal communication]). For this type of hy- 
pothesis the failure to activate B cells by bivalent anti-Ig antibodies would be 
explained by the lack of the first, specific, signal. However, this first signal is not 
necessary for the nonspecific activation of B cells by mitogens. All these specific 
hypotheses have in common that the first, specific,  signal is necessary but not 
sufficient for cell activation. Our model states that the antigen binding by Ig re- 
ceptors does not constitute any signal in the activation process, since the con- 
frontation of B cells with nonmitogenic molecules (TD antigens) does not lead 
to activation, and because full antibody production can be induced in all B cells 
without the participation of any specific event, involving combining sites of the 
surface Ig molecules (e.g. B-cell mitogens). Only one signal seems to be neces- 
sary to B-cell activation, and this signal is totally nonspecific, probably mediated 
by receptors on the cell membrane that are not Ig receptors and that clearly are 
not the combining sites of Ig receptors. Molecules competent to interact with 
such receptors are B-cell mitogens, which induce increased antibody production 
and division in all mature B cells, irrespective of their specificities,  and T  cell- 
produced nonspecific factors, which in vitro can be shown to induce increased 
antibody synthesis of all specificities  in the absence of antigen (38). Moreover 
cross-linking does not seem to be necessary for B-cell induction, since molecules 
of  tool  wt  as  low as  2,000  can  activate  B  cells  very  efficiently,  2 and  anti- 
body-producing cells can be activated directly by this type of ligand without the 
participation of helper cells such as macrophages2 
The findings  presented in this paper support a "one nonspecific signal" concept 
of B-cell activation, argue against the active role of antigen-binding Ig receptors 
for the triggering event, and demonstrate that specific induction of antibody 
synthesis is not only compatible with mitogenic triggering, but appears to be 
the only satisfactory way to interprete the findings that TI antigens are also 
nonspecific B-cell  mitogens. The present  hypothesis also  excludes the possi- 
2 Coutinho, A., G. M611er, and W. Richter. Molecular basis of B  cell activation. I. Molecu- 
lar weight requirements for mitogenicity by modified  and  native dextrans. Vogt, W., H. Ruh, 
B.  Wagner,  and  T.  Diamanstein.  1973. Stimulation of DNA synthesis  in  mouse lymphoid 
cells by polyanions in vitro. II. Relationship between adjuvant  activity and  stimulation of 
DNA synthesis by polyanions. Manuscripts in preparation. 
Coutinho, A., E. Gronowicz,  and  G. MSller.  Triggering of polyclonal antibody synthesis 
by LPS does not require adherent cells. Manuscript submitted for publication. A.  COUTINHO,  E.  GRONOWICZ,  W.  W.  BULLOCK,  G.  MOLLER  89 
bility of tolerance induction by subimmunogenic concentrations of these anti- 
gens (low zone) and explains  the ease of high-zone  tolerance induction (cell pa- 
ralysis) both in vivo and in vitro by TI antigens. This suggestion has received 
experimental support from several sources (21, 39-43). However, it should be 
kept in mind that these findings,  and consequently the hypothesis, have been 
limited to induction of primary IgM responses.  Additional  requirements  that 
seem to be needed for IgG responses remain to be established. 
SUMMARY 
The present experiments were performed in order to analyze the mechanism 
by which thymus-independent antigens (nonspecific B-cell mitogens) can induce 
specific immune responses to antigenic determinants present on the same mole- 
cule. The hapten NNP was coupled to the B-cell mitogen, lipopolysaccharide 
(LPS). The conjugate retained full  mitogenic  activity and  bound specifically 
to NNP-reactive cells. NNP-LPS activated polyclonal as well as specific anti- 
NNP antibody synthesis, hut the optimal concentrations for induction of spe- 
cific anti-NNP  cells were several orders of magnitude lower than  the concen- 
trations required for polyclonal activation. These low concentrations failed to 
activate  nonspecific  cells,  but they induced specific  thymus-independent  re- 
sponses of high-avidity NNP-specific cells with the typical kinetics of antigenic 
responses  in vitro. Furthermore, hapten-specific  cells were paralyzed by NNP- 
LPS concentrations  that were optimal for induction of polyclonal activation. 
Specific activation and paralysis could be abolished by free hapten indicating 
that selective binding of NNP-LPS to hapten-specific cells was responsible for 
the specificity of the response. However, the triggering  signal lacked specificity, 
since high-avidity specific anti-NNP cells could still be activated by stimulating 
concentrations of NNP-LPS in the presence of free hapten, even though the Ig 
receptor combining sites were presumably occupied by NNP. 
The findings show that B cells with specific Ig receptors for the antigenic de- 
terminants  on mitogen molecules  preferentially bind these molecules  and be- 
come activated at concentrations still unsufficient  to trigger other B cells that 
lack specific receptors. It is suggested that activation for primary IgM responses 
in B cells is the result of "one nonspecific signal." This nonspecific signal is pro- 
vided by the mitogenic properties of some antigens (highly thymus independent 
or, alternatively, by nonspecific T-cell factors (for highly T cell-dependent anti- 
gens),  or both, and the surface structures responsible for triggering  are not the 
Ig receptors. The specific Ig receptors only act as passive focusing  devices for 
nonspecific  stimuli,  entitling  the cell to be selectively activated,  even though 
both the signal and the receptors for the triggering  are nonspecific. 
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